Claims for Patent: 11,324,710

Summary for Patent: 11,324,710

Title:	Topical pharmaceutical compositions for treating skin conditions
Abstract:	Topical pharmaceutical compositions for treating a skin condition or disorder are provided. The topical pharmaceutical compositions can be formulated as lotions containing a therapeutically effective amount of an active agent, such as tretinoin, a viscosity increasing agent, and advantageously small amounts of both a polymeric emulsifier and an oil component. The topical compositions of the present invention are tolerated exceptionally well by subjects to whom the compositions are administered.
Inventor(s):	Bhatt; Varsha (San Francisco, CA), Pillai; Radhakrishnan (Santa Rosa, CA)
Assignee:	BAUSCH HEALTH IRELAND LIMITED (Dublin, IE)
Application Number:	16/376,583
Patent Claims:	1. A method for treating acne vulgaris in a subject, the method comprising applying once daily to an affected area of skin of the subject a topical pharmaceutical composition comprising: tretinoin an active agent in an amount from 0.01% to 1% by weight of the composition; a polymeric emulsifier, wherein the polymeric emulsifier comprises a cross-linked copolymer of acrylic acid and C10-C30 alkyl acrylate, and wherein the polymeric emulsifier is present in an amount from 0.02% to 0.08% by weight of the composition; a viscosity increasing agent, wherein the viscosity increasing agent comprises a cross-linked homopolymer of an acrylic acid, and wherein the viscosity increasing agent is present in an amount from 0.1% to 2% by weight of the composition; a moisturizing agent, wherein the moisturizing agent comprises soluble collagen and sodium hyaluronate, and wherein the moisturizing agent is present in an amount from 5% to 10% by weight of the composition; an oil component comprising one or more oils, wherein the oil component is present in an amount from 1% to 3.5% by weight of the composition; and water; and wherein the composition is formulated as a lotion. 2. The method of claim 1, wherein the pharmaceutical composition comprises the tretinoin in an amount of 0.05% by weight of the composition. 3. The method of claim 1, wherein the polymeric emulsifier is a carbomer copolymer type B. 4. The method of claim 1, wherein the oil component comprises mineral oil, light mineral oil, petrolatum, fatty alcohols, monocarboxylic acid esters, dicarboxylic acid esters, medium-chain triglycerides, long-chain triglycerides, or a combination thereof. 5. The method of claim 4, wherein the oil component comprises mineral oil, light mineral oil, petrolatum, or a combination thereof. 6. The method of claim 1, wherein the oil component consists of mineral oil. 7. The method of claim 1, wherein the viscosity increasing agent is a carbomer homopolymer type A. 8. The method of claim 1, wherein the viscosity increasing agent is present in an amount from 0.4% to 1% by weight of the composition. 9. The method of claim 8, wherein the viscosity increasing agent is present in an amount from 0.6% to 1% by weight of the composition. 10. The method of claim 1, wherein the composition has a viscosity from 2,500 cP to 18,000 cP. 11. The method of claim 10, wherein the composition has a viscosity from 8,000 cP to 12,000 cP. 12. The method of claim 10, wherein the composition further comprises one or more preservatives, antioxidants, and/or humectants. 13. The method of claim 10, wherein the composition further comprises a neutralizing agent that maintains the pH of the composition at a pH from 5 to 6. 14. The method of claim 12, wherein the pharmaceutical composition comprises: the tretinoin in an amount of 0.05% by weight of the composition; the polymeric emulsifier in an amount of 0.05% by weight of the composition, wherein the polymeric emulsifier is a carbomer copolymer type B; the viscosity increasing agent in an amount from 0.6% to 1% by weight of the composition; wherein the viscosity increasing agent is carbomer homopolymer type A; the oil component in an amount up to 3% by weight of the composition, wherein the oil component consists of mineral oil; the moisturizing agent in an amount from 5% to 10% by weight of the composition; a humectant in an amount from 5% to 20% by weight of the composition, wherein the humectant is glycerin; an antioxidant in an amount from 0.1% to 2% by weight of the composition, wherein the antioxidant is butylated hydroxytoluene; a wetting agent in an amount from 0.05% to 0.5% by weight of the composition, wherein the wetting agent is octoxynol-9; optionally, one or more preservatives in an amount from 0.25% to 5% by weight of the composition, wherein the one or more preservatives are benzyl alcohol, methyl paraben, or a combination thereof; and optionally, a neutralizing agent, wherein the neutralizing agent is trolamine.